Cash flow InterCure Ltd.

Stocks

INCR

IL0011063760

Healthcare Facilities & Services

Market Closed - TEL AVIV STOCK EXCHANGE 10:29:11 2026-09-10 EDT			5-day change	1st Jan Change
1,614.00 ^ILa	-1.41%		-0.49%	-0.25%

09-08	InterCure Regains Nasdaq Compliance	MT
08-24	InterCure Ltd. announced that it has received ILS 21.711643 million in funding from Bennu Pharma Fund Ltd and other investors.	CI

6ba67dce4eda32b15e2d.c4HNcbb3ZB54p7uy0498ICST5zDdV5Ame1blc7tRTbU.NOWcMIaxJ2YI7fjapMg_VmvG1HO7YvpTPQGEPPw3BPI3rJcTwKdTS02f1A

Published financial data: INTERCURE LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (ILS)	2022 (ILS)	2023 (ILS)	2024 (ILS)	2025 (ILS)
Revenues	220M	389M	356M	239M	270M
Total Revenues	220M	389M	356M	239M	270M
Cost of Goods Sold, Total	117M	217M	247M	197M	229M
Gross Profit	103M	172M	109M	42.05M	40.7M
Selling General & Admin Expenses, Total	50.42M	92.62M	95.88M	108M	93.4M
Stock-Based Compensation (IS)	6.45M	8.91M	2.59M	2.28M	2.43M
R&D Expenses	1.24M	632K	388K	414K	390K
Other Operating Expenses	14.05M	29M	11.24M	19.35M	11.73M
Other Operating Expenses, Total	72.15M	131M	110M	130M	108M
Operating Income	30.41M	40.85M	-1.5M	-87.89M	-67.24M
Interest Expense, Total	-418K	-630K	-726K	-20.64M	-19.66M
Interest And Investment Income	130K	844K	5.38M	2.7M	1.56M
Net Interest Expenses	-288K	214K	4.65M	-17.94M	-18.11M
Income (Loss) On Equity Invest.	-	-	-	-	296K
Currency Exchange Gains (Loss)	-4.54M	7.33M	-46K	-23K	1.42M
Other Non Operating Income (Expenses)	-4.63M	-14.32M	-24.32M	-2.15M	-171K
EBT, Excl. Unusual Items	20.96M	34.07M	-21.22M	-108M	-83.8M
Merger & Related Restructuring Charges	-356K	-625K	-356K	-	-
Impairment of Goodwill	-	-	-63.1M	-	-
Gain (Loss) On Sale Of Investments	-1.87M	-174K	-3M	-12.22M	-30.07M
Asset Writedown	-	-	-4.59M	-	-
Other Unusual Items	-	10.57M	30.98M	32.9M	69.77M
EBT, Incl. Unusual Items	18.74M	43.84M	-61.28M	-87.32M	-44.1M
Income Tax Expense	11.44M	93K	2.25M	-14.53M	-7.32M
Earnings From Continuing Operations	7.3M	43.75M	-63.53M	-72.79M	-36.78M
Net Income to Company	7.3M	43.75M	-63.53M	-72.79M	-36.78M
Minority Interest	-2.6M	1.07M	1.57M	5M	1.07M
Net Income - (IS)	4.69M	44.82M	-61.96M	-67.8M	-35.71M
Net Income to Common Incl Extra Items	4.69M	44.82M	-61.96M	-67.8M	-35.71M
Net Income to Common Excl. Extra Items	4.69M	44.82M	-61.96M	-67.8M	-35.71M
Per Share Items
Net EPS - Basic	0.61	4.94	-6.8	-7.39	-3.32
Basic EPS - Continuing Operations	0.61	4.94	-6.8	-7.39	-3.32
Basic Weighted Average Shares Outstanding	7.7M	9.07M	9.11M	9.17M	10.75M
Net EPS - Diluted	0.5	4.94	-6.8	-7.4	-3.32
Diluted EPS - Continuing Operations	0.5	4.94	-6.8	-7.4	-3.32
Diluted Weighted Average Shares Outstanding	9.78M	9.08M	9.11M	9.17M	10.75M
Normalized Basic EPS	1.36	2.47	-1.28	-6.81	-4.77
Normalized Diluted EPS	1.07	2.46	-1.28	-6.81	-4.77
Supplemental Items
EBITDA	35.53M	48.34M	6.68M	-78.22M	-55.34M
EBITA	30.41M	40.85M	-1.5M	-87.89M	-67.24M
EBIT	30.41M	40.85M	-1.5M	-87.89M	-67.24M
EBITDAR	38.1M	49.32M	8.01M	-77.07M	-54.56M
Effective Tax Rate - (Ratio)	61.06	0.21	-3.67	16.64	16.6
Total Current Taxes	9.5M	17.71M	6.29M	-846K	305K
Total Deferred Taxes	1.94M	-17.62M	-4.05M	-13.68M	-7.62M
Normalized Net Income	10.5M	22.36M	-11.69M	-62.5M	-51.3M
Interest on Long-Term Debt	523K	719K	726K	820K	779K
Supplemental Operating Expense Items
Selling and Marketing Expenses	23.21M	56.53M	53.27M	54.22M	52.51M
General and Administrative Expenses	27.2M	36.08M	42.61M	53.67M	40.89M
Research And Development Expense From Footnotes	1.24M	632K	388K	414K	390K
Net Rental Expense, Total	2.57M	988K	1.33M	1.15M	781K
Imputed Operating Lease Interest Expense	150K	27.35K	34.26K	935K	623K
Imputed Operating Lease Depreciation	2.42M	961K	1.3M	217K	158K
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	6.45M	8.91M	2.59M	2.28M	2.43M
Total Stock-Based Compensation	6.45M	8.91M	2.59M	2.28M	2.43M

Fiscal Period: December	2021 (ILS)	2022 (ILS)	2023 (ILS)	2024 (ILS)	2025 (ILS)
Assets
Cash And Equivalents	196M	233M	101M	78.32M	46.47M
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	330K	205K	187K	333K	209K
Total Cash And Short Term Investments	197M	233M	101M	78.65M	46.68M
Accounts Receivable, Total	18.59M	40.76M	61.12M	52.45M	21.78M
Other Receivables	14.26M	24.84M	69.12M	87.19M	127M
Notes Receivable	4.68M	64.35M	40.53M	40.86M	6.17M
Total Receivables	37.53M	130M	171M	180M	154M
Inventory	62.31M	120M	105M	120M	108M
Prepaid Expenses	4.98M	3.13M	1.28M	1.51M	1.14M
Restricted Cash	21.08M	13.91M	9.66M	1.32M	2.03M
Other Current Assets, Total	13.71M	7.58M	30.29M	9.52M	4.42M
Total Current Assets	336M	507M	419M	392M	317M
Gross Property Plant And Equipment	98M	126M	138M	160M	174M
Accumulated Depreciation	-11.49M	-23.19M	-40.17M	-54.46M	-71.52M
Net Property Plant And Equipment	86.51M	103M	97.47M	105M	103M
Long-term Investments	2.56M	22.56M	1.92M	2.15M	1.02M
Goodwill	258M	284M	221M	225M	219M
Loans Receivable Long-Term	-	20M	18.45M	-	-
Deferred Tax Assets Long-Term	3.02M	20.64M	24.68M	38.36M	45.99M
Other Long-Term Assets, Total	1K	-	4.21M	423K	4.79M
Total Assets	686M	958M	787M	763M	691M
Liabilities
Accounts Payable, Total	64.47M	126M	78.44M	77.54M	68.14M
Accrued Expenses, Total	5.96M	10.59M	12.5M	14.35M	17.27M
Short-term Borrowings	1.72M	1.09M	-	-	11M
Current Portion of Long-Term Debt	70.56M	127M	88.19M	69.44M	88.8M
Current Portion of Leases	3.31M	4.35M	4.64M	4.79M	4.26M
Unearned Revenue Current, Total	2.9M	8.06M	-	-	-
Other Current Liabilities	44.66M	35.63M	42.1M	60.64M	24.89M
Total Current Liabilities	194M	313M	226M	227M	214M
Long-Term Debt	11.95M	99.68M	82.2M	114M	59.46M
Long-Term Leases	21.37M	23.1M	20.64M	23.2M	19.49M
Pension & Other Post Retirement Benefits	224K	1.02M	841K	973K	881K
Other Non Current Liabilities	-1K	-	-	-	-
Total Liabilities	227M	437M	330M	365M	294M
Common Stock, Total	624M	632M	643M	659M	676M
Retained Earnings	-186M	-142M	-204M	-278M	-315M
Comprehensive Income and Other	10.93M	10.93M	15.95M	15.95M	35.54M
Total Common Equity	448M	501M	455M	397M	397M
Minority Interest	11.16M	20.17M	1.95M	702K	-164K
Total Equity	459M	521M	457M	398M	396M
Total Liabilities And Equity	686M	958M	787M	763M	691M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	9.03M	9.11M	9.11M	9.43M	10.94M
ECS Total Common Shares Outstanding	9.03M	9.11M	9.11M	9.43M	10.94M
Book Value / Share	49.63	55	49.93	42.09	36.26
Tangible Book Value	190M	217M	234M	172M	177M
Tangible Book Value Per Share	21.04	23.82	25.68	18.27	16.21
Total Debt	109M	255M	196M	211M	183M
Net Debt	-87.64M	22.37M	94.35M	133M	136M
Debt Equivalent Oper. Leases	20.59M	7.9M	10.64M	9.22M	6.25M
Minority Interest, Total (Incl. Fin. Div)	11.16M	20.17M	1.95M	702K	-164K
Equity Method Investments, Total	-	20M	-	-	901K
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Work In Process, Total	23.06M	69.99M	45M	57.6M	89.88M
Inventories - Finished Goods, Total	39.26M	50.14M	60.47M	62.71M	18.12M
Buildings, Total	58.8M	70.13M	78.2M	91.29M	102M
Machinery, Total	12.08M	22.42M	23.41M	24.83M	28M
Full Time Employees	350	370	270	320	285
Accumulated Allowance for Doubtful Accounts (Supple)	913K	894K	5.18M	7.75M	6.98M

Fiscal Period: December	2021 (ILS)	2022 (ILS)	2023 (ILS)	2024 (ILS)	2025 (ILS)
Net Income	4.69M	44.82M	-61.96M	-67.8M	-35.71M
Depreciation & Amortization - CF	7.39M	11.7M	13.17M	15.37M	17.15M
Depreciation & Amortization, Total	7.39M	11.7M	13.17M	15.37M	17.15M
(Gain) Loss From Sale Of Asset	-	-	412K	-932K	3.27M
(Gain) Loss on Sale of Investments - (CF)	1.87M	172K	661K	-371K	2.15M
Asset Writedown & Restructuring Costs	-	-	67.69M	-	-
Provision for Credit Losses	-	-	2.33M	-	-
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	6.45M	8.91M	2.59M	2.28M	2.43M
Other Operating Activities, Total	6.27M	-11.31M	12.65M	-6.29M	8.68M
Change In Accounts Receivable	8.39M	-18.29M	-23.49M	8.43M	30.84M
Change In Inventories	-15.48M	-75.19M	34.66M	-13.24M	10.98M
Change In Accounts Payable	2.79M	57.03M	-47.63M	-8.9M	-8.82M
Change in Other Net Operating Assets	2.64M	33.42M	-54.72M	4.52M	-14.13M
Cash from Operations	25.02M	51.27M	-53.63M	-66.93M	16.84M
Capital Expenditure	-14.03M	-19.74M	-2.62M	-4.38M	-3.55M
Sale of Property, Plant, and Equipment	-	-	25K	-	-
Cash Acquisitions	-19.09M	-14.48M	-4.2M	1.11M	-114K
Divestitures	-	-	-	-253K	2.43M
Sale (Purchase) of Intangible assets	-	-	-	-450K	-
Investment in Marketable and Equity Securities, Total	-1.25M	-	-	-	-651K
Net (Increase) Decrease in Loans Originated / Sold - Investing	-7.34M	-95.23M	6.13M	13.07M	-349K
Other Investing Activities, Total	-23.5M	-13.04M	5.44M	8.59M	242K
Cash from Investing	-65.21M	-142M	4.77M	17.69M	-1.99M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	75.46M	263M	62.73M	188M	21.15M
Total Debt Issued	75.46M	263M	62.73M	188M	21.15M
Long-Term Debt Repaid, Total	-9.63M	-126M	-125M	-181M	-50.28M
Total Debt Repaid	-9.63M	-126M	-125M	-181M	-50.28M
Issuance of Common Stock	137M	-	-	34M	1.5M
Other Financing Activities, Total	1K	-17.28M	-20.91M	-15.29M	-19.03M
Cash from Financing	203M	120M	-82.89M	26.46M	-46.66M
Foreign Exchange Rate Adjustments	-4.54M	7.16M	297K	-39K	-44K
Miscellaneous Cash Flow Adjustments	-1K	-	-	-	-
Net Change in Cash	158M	36.37M	-131M	-22.82M	-31.85M
Supplemental Items
Cash Interest Paid	5.12M	17.28M	20.91M	15.19M	19.03M
Cash Income Tax Paid (Refund)	11.8M	7.97M	7.61M	12.89M	-306K
Levered Free Cash Flow	7.27M	-46.73M	-58.34M	-31.19M	-37.43M
Unlevered Free Cash Flow	7.54M	-46.34M	-57.89M	-18.28M	-25.14M
Change In Net Working Capital	11.29M	72.74M	70.09M	-23.82M	-854K
Net Debt Issued / Repaid	65.83M	138M	-61.98M	7.74M	-29.13M

Fiscal Period: December	2021 (ILS)	2022 (ILS)	2023 (ILS)	2024 (ILS)	2025 (ILS)
Profitability
Return on Assets	3.75	3.09	-0.11	-7.09	-5.78
Return on Total Capital	4.39	3.77	-0.13	-8.71	-7.07
Return On Equity %	1.94	8.83	-12.99	-17.03	-9.27
Return on Common Equity	1.3	9.44	-12.96	-15.91	-9
Margin Analysis
Gross Profit Margin %	46.69	44.25	30.54	17.61	15.06
SG&A Margin	22.95	23.83	26.97	45.17	34.57
EBITDA Margin %	16.17	12.44	1.88	-32.75	-20.48
EBITA Margin %	13.84	10.51	-0.42	-36.8	-24.89
EBIT Margin %	13.84	10.51	-0.42	-36.8	-24.89
Income From Continuing Operations Margin %	3.32	11.26	-17.87	-30.48	-13.61
Net Income Margin %	2.14	11.53	-17.43	-28.38	-13.22
Net Avail. For Common Margin %	2.14	11.53	-17.43	-28.38	-13.22
Normalized Net Income Margin	4.78	5.75	-3.29	-26.17	-18.99
Levered Free Cash Flow Margin	3.31	-12.02	-16.41	-13.06	-13.85
Unlevered Free Cash Flow Margin	3.43	-11.92	-16.28	-7.66	-9.31
Asset Turnover
Asset Turnover	0.43	0.47	0.41	0.31	0.37
Fixed Assets Turnover	3.14	4.1	3.54	2.36	2.6
Receivables Turnover (Average Receivables)	14.15	13.1	6.98	4.21	7.28
Inventory Turnover (Average Inventory)	2.88	2.38	2.01	1.74	2.01
Short Term Liquidity
Current Ratio	1.74	1.62	1.85	1.73	1.48
Quick Ratio	1.19	0.95	1.03	0.96	0.91
Operating Cash Flow to Current Liabilities	0.13	0.16	-0.24	-0.3	0.08
Days Sales Outstanding (Average Receivables)	25.8	27.87	52.29	87.02	50.14
Days Outstanding Inventory (Average Inventory)	126.79	153.67	181.5	209.95	181.56
Average Days Payable Outstanding	94.56	126.68	175.81	134.88	122.41
Cash Conversion Cycle (Average Days)	58.04	54.86	57.99	162.09	109.29
Long Term Solvency
Total Debt/Equity	23.72	48.93	42.81	53.16	46.17
Total Debt / Total Capital	19.17	32.85	29.98	34.71	31.59
LT Debt/Equity	7.26	23.55	22.5	34.5	19.92
Long-Term Debt / Total Capital	5.87	15.81	15.76	22.52	13.63
Total Liabilities / Total Assets	33.09	45.57	41.9	47.85	42.6
EBIT / Interest Expense	72.75	64.85	-2.07	-4.26	-3.42
EBITDA / Interest Expense	90.44	83.42	16.06	-3.51	-2.55
(EBITDA - Capex) / Interest Expense	56.88	52.08	12.46	-3.72	-2.73
Total Debt / EBITDA	2.88	4.86	16.78	-2.92	-3.65
Net Debt / EBITDA	-2.32	0.43	8.09	-1.83	-2.72
Total Debt / (EBITDA - Capex)	4.58	7.78	21.64	-2.75	-3.41
Net Debt / (EBITDA - Capex)	-3.69	0.68	10.43	-1.73	-2.54
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	237.78	76.93	-8.52	-32.82	13.13
Gross Profit, 1 Yr. Growth %	205.36	67.71	-36.86	-61.28	-3.21
EBITDA, 1 Yr. Growth %	2.39K	36.06	-86.18	-1.04K	-29.25
EBITA, 1 Yr. Growth %	-2.62K	34.35	-103.68	-83.8K	-23.49
EBIT, 1 Yr. Growth %	-2.62K	34.35	-103.68	-83.8K	-23.49
Earnings From Cont. Operations, 1 Yr. Growth %	-120.24	499.88	-245.22	14.58	-49.47
Net Income, 1 Yr. Growth %	-112.6	855.63	-238.24	9.42	-47.33
Normalized Net Income, 1 Yr. Growth %	-656.39	113.07	-152.27	485.02	-17.92
Diluted EPS Before Extra, 1 Yr. Growth %	-106.82	798.4	-237.62	8.82	-55.1
Accounts Receivable, 1 Yr. Growth %	49.16	119.21	49.96	-14.18	-58.47
Inventory, 1 Yr. Growth %	227.12	92.79	-24.74	14.07	-10.22
Net Property, Plant and Equip., 1 Yr. Growth %	61.79	19.22	-5.49	7.97	-2.31
Total Assets, 1 Yr. Growth %	110.35	37.54	-17.89	-3.06	-9.44
Tangible Book Value, 1 Yr. Growth %	125.06	20.8	7.79	-26.35	2.87
Common Equity, 1 Yr. Growth %	63.21	11.89	-9.21	-12.78	-0.11
Cash From Operations, 1 Yr. Growth %	220.65	70.12	-204.61	24.79	-125.16
Capital Expenditures, 1 Yr. Growth %	-32.69	40.73	-86.73	67.09	-18.9
Levered Free Cash Flow, 1 Yr. Growth %	-156.3	-742.36	-12.57	-56.7	20.02
Unlevered Free Cash Flow, 1 Yr. Growth %	-159.07	-714.87	-12.74	-67.86	37.52
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	396.09	144.47	27.22	-21.61	-12.83
Gross Profit, 2 Yr. CAGR %	374.99	126.3	2.9	-50.56	-38.78
EBITDA, 2 Yr. CAGR %	-34.2	385.81	-57.76	22.73	104.21
EBITA, 2 Yr. CAGR %	-39.43	482.27	-77.64	47.81	2.43K
EBIT, 2 Yr. CAGR %	-39.43	482.27	-77.64	47.81	2.43K
Earnings From Cont. Operations, 2 Yr. CAGR %	11.26	10.18	195.15	28.99	-23.91
Net Income, 2 Yr. CAGR %	-10.77	9.72	263.47	22.99	-24.08
Normalized Net Income, 2 Yr. CAGR %	-55.9	244.29	6.67	68.66	119.13
Diluted EPS Before Extra, 2 Yr. CAGR %	-37.12	-17.9	251.62	22.38	-30.1
Accounts Receivable, 2 Yr. CAGR %	242.29	80.82	81.31	13.44	-40.3
Inventory, 2 Yr. CAGR %	266.27	151.13	30.1	-7.34	1.2
Net Property, Plant and Equip., 2 Yr. CAGR %	64.04	38.88	6.15	1.02	2.7
Total Assets, 2 Yr. CAGR %	55.94	71.35	6.27	-10.78	-6.3
Tangible Book Value, 2 Yr. CAGR %	46.92	60.39	14.11	-10.9	-12.95
Common Equity, 2 Yr. CAGR %	32.3	35.14	0.79	-11.01	-6.66
Cash From Operations, 2 Yr. CAGR %	47.06	154.81	33.41	14.26	-43.96
Capital Expenditures, 2 Yr. CAGR %	-29.4	-2.67	-56.79	-52.92	16.41
Levered Free Cash Flow, 2 Yr. CAGR %	-40.17	90.17	187.62	-35.9	-27.91
Unlevered Free Cash Flow, 2 Yr. CAGR %	-37.3	90.59	181.33	-47.66	-33.52
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	251.81	76.16	2.83	-11.41
Gross Profit, 3 Yr. CAGR %	-	235.72	47.87	-25.71	-38.15
EBITDA, 3 Yr. CAGR %	51.96	-16.17	48.31	27.83	2.15
EBITA, 3 Yr. CAGR %	44.24	-21.01	7.64	43	18.68
EBIT, 3 Yr. CAGR %	44.24	-21.01	7.64	43	18.68
Earnings From Cont. Operations, 3 Yr. CAGR %	-17.09	95.08	20.8	115.31	-5.62
Net Income, 3 Yr. CAGR %	-28.43	96.66	18.5	143.6	-7.29
Normalized Net Income, 3 Yr. CAGR %	11.18	-25.45	83.67	82.56	32.66
Diluted EPS Before Extra, 3 Yr. CAGR %	-48.03	57.5	-2.47	137.84	-12.39
Accounts Receivable, 3 Yr. CAGR %	-	195.04	69.89	41.3	-18.85
Inventory, 3 Yr. CAGR %	-	195.73	76.91	24.52	-8.31
Net Property, Plant and Equip., 3 Yr. CAGR %	901.97	47.48	22.16	6.75	-0.1
Total Assets, 3 Yr. CAGR %	167.34	50.29	34.09	3.06	-10.34
Tangible Book Value, 3 Yr. CAGR %	112.98	35.12	40.49	-1.38	-6.53
Common Equity, 3 Yr. CAGR %	183.5	25.11	18.36	-3.95	-7.52
Cash From Operations, 3 Yr. CAGR %	156.3	64.25	89.38	30.47	-31
Capital Expenditures, 3 Yr. CAGR %	432.33	-11.15	-49.91	-32.18	-43.56
Levered Free Cash Flow, 3 Yr. CAGR %	40.04	32	65.28	64.14	-21
Unlevered Free Cash Flow, 3 Yr. CAGR %	31.82	34.21	65.56	35.72	-27.77
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	92.97	32.96
Gross Profit, 5 Yr. CAGR %	-	-	-	56.04	3.92
EBITDA, 5 Yr. CAGR %	-	111.39	-7.98	-0.95	93.35
EBITA, 5 Yr. CAGR %	98.82	104.26	-31.73	1.18	123.53
EBIT, 5 Yr. CAGR %	98.82	104.26	-31.73	1.18	123.53
Earnings From Cont. Operations, 5 Yr. CAGR %	96.19	51.28	37.78	65.33	0.41
Net Income, 5 Yr. CAGR %	79.61	52.02	37.09	62.99	-0.83
Normalized Net Income, 5 Yr. CAGR %	68.54	71.67	8.88	2.98	93.59
Diluted EPS Before Extra, 5 Yr. CAGR %	41.23	24.6	13.8	42.38	-14.64
Accounts Receivable, 5 Yr. CAGR %	-	-	-	101.3	11.81
Inventory, 5 Yr. CAGR %	-	-	-	91.72	41.49
Net Property, Plant and Equip., 5 Yr. CAGR %	545.86	662.55	308.2	26.77	13.97
Total Assets, 5 Yr. CAGR %	89.96	107.1	85.39	21.99	16.18
Tangible Book Value, 5 Yr. CAGR %	51.15	58.48	64.11	14.39	16.01
Common Equity, 5 Yr. CAGR %	79.44	87.35	87.46	9.17	7.63
Cash From Operations, 5 Yr. CAGR %	86.46	121.3	104.87	42.06	16.36
Capital Expenditures, 5 Yr. CAGR %	357.49	-	94.95	-31.08	-29.82
Levered Free Cash Flow, 5 Yr. CAGR %	117.83	86.57	85.6	8.95	23.7
Unlevered Free Cash Flow, 5 Yr. CAGR %	139.29	94.92	77.45	-0.94	14.53